NSRX

AS OF

Jan 14, 12:31 PM (EDT)

Price

$7.10

Change

+$0.10 (+1.43%)

Capitalization

63.42M

42 days until earnings call

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

NSRX

Stock ticker: ASE

PRICE

CHANGE

CAPITALIZATION

Nasus Pharma (NSRX) Ownership - Who owns Nasus Pharma?

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Details

Group

Domestic Stock Funds

Fundamentals

NSRX

Capitalization

63.4M

P/E Ratio

N/A

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash

N/A

Total Cash/Share

N/A

Total Debt

N/A

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

Revenue

N/A

ROE

N/A

Book Value

N/A

P/B Ratio

N/A

Cash Flow

N/A

Earnings

N/A

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

N/A

Current Ratio

N/A

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

N/A

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

N/A

Shares Held By Institutions

21.6K

Shares Outstanding - Current

9.06M

Total Liabilities

N/A

Total Volume MTD

N/A

Value

N/A

Gain YTD

-23.496

View a ticker or compare two or three

Compare

NSRX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.

View AI-Driven Trading for NSRX

A.I. Advisor

published General Information

General Information

Industry PharmaceuticalsMajor

Profile

Fundamentals

Details